March 15, 2016 / 4:12 PM / a year ago

BUZZ-Aralez Pharmaceuticals Inc: Hits over 2-1/2-year low

1 Min Read

** Drug developer's U.S.-listed shares fall 18 pct to $4.76, lowest since May 2013

** Reports Q4 revenue of $6 mln vs $9.9 mln year earlier primarily due to increased costs associated with upcoming launch of its new drug Yosprala

** Net loss was 40 cents per share, compared with a profit of 21 cents per share year earlier

** Up to Monday's close, stock had fallen 15 pct this year

0 : 0
  • narrow-browser-and-phone
  • medium-browser-and-portrait-tablet
  • landscape-tablet
  • medium-wide-browser
  • wide-browser-and-larger
  • medium-browser-and-landscape-tablet
  • medium-wide-browser-and-larger
  • above-phone
  • portrait-tablet-and-above
  • above-portrait-tablet
  • landscape-tablet-and-above
  • landscape-tablet-and-medium-wide-browser
  • portrait-tablet-and-below
  • landscape-tablet-and-below